[1] |
LIANG Xiumei, CHEN Weiyi, ZHOU Zihan, MA Liang, WU Yun, LU Xiangning, XIANG Bangde, YU Hongping, LYU Hanbin.
Analysis of survival characteristics in liver cancer inpatients: a 10-year follow-up cohort from a cancer hospital in Guangxi (2010—2020)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 145-149.
|
[2] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[3] |
ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing.
Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 447-453.
|
[4] |
LI Huadao, LIN Liqiao, LIANG Yubing, HUANG Enhao, PAN Linghui.
Effects of Herba Houttuyniae on the biological behavior of liver cancer cells and a network pharmacology analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 277-284.
|
[5] |
DONG Jiaqi, FANG Tao, OU Yong, WEI Jingyi, HU Longquan, LI Yuanyuan, CHAO Xu.
Vitexicarpin inhibits the proliferation of liver cancer cells by regulating glucose metabolism reprogramming
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 615-622.
|
[6] |
ZHANG Zhihong, CUI Wangfei, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Prediction model of high-risk population of upper gastrointestinal cancer and precancerous lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 549-555.
|
[7] |
ZHANG Zhenneng, TAN Siying, TANG Qinfen, HUANG Tianren.
Combined effect of Entecavir and Chloroquine on biological function of liver cancer HepG2 cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 176-180.
|
[8] |
CAI Xinlian, HUANG Yueli, ZHONG Yi, LIU Aiqun.
Analysis of the opportunistic screening results of upper gastrointestinal cancer in Guangxi,2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 662-666.
|
[9] |
LEI Ruijiao, ZHANG Meizhen, WANG Le, FANG Zhimei, WANG Youqing, LI Huizhang, ZHU Chen, DU Lingbin.
Analysis of screening results of urban cancer early diagnosis and treatment program in Quzhou city,Zhejiang province ,2014—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 618-623.
|
[10] |
ZHU Zhanhui, CAO Ji, YU Jiahua, LI Qiulin, YANG Ziyi, GE Lianying, RONG Minhua.
Assessment of cancer risk and analysis of screening results of cancer screening program in urban Guangxi from 2014 to 2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 681-685.
|
[11] |
Chen Qihuang,Deng Wei,Cao Ji,Cai Zhengmin,Ge Lianying.
Epidemiology of HBV infection and viral genotypes from liver cancer prevention screening in Guigang City, Guangxi Province
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 382-386.
|
[12] |
ZHANG Liran,WANG Xinguo,XIE Fengxiang,ZHAO Dongman,FAN Botao,LI Xin,QI Debo.
Liquid-based cytology screening for cervical cancer in Lanling district
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(4): 255-259.
|
[13] |
XIE Qiang-ming,LIU Kun,CHEN Shan.
Early cancer screening and treatment in Changsha, China: assessment for 2012-2013
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(3): 243-246.
|
[14] |
CUI Yan-ping,XIAO Shu-jun,YU Wen-jie,et al..
Application of visual inspection with acetic acid staining for cervical cancer screening in rural area
[J]. Chinese Journal of Oncology Prevention and Treatment, 2010, 2(01): 12-14.
|